NewAmsterdam Pharma N.V. (NAMSW)
7.14
-4.21 (-37.09%)
At close: Apr 01, 2025, 3:15 PM
6.90
-3.36%
After-hours: Apr 01, 2025, 04:00 PM EDT
NewAmsterdam Pharma Revenue
NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a undefined% growth. For the quarter ending December 31, 2024, NewAmsterdam Pharma generated $12.77M in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
1.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 45.56M | +257.00% |
| Dec 31, 2023 | 12.76M | -86.69% |
| Dec 31, 2022 | 95.91M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |